Trial
NCT00780455
Rehabilitation Study in MS Patients
Phase IVTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Bayer
Collaborators
—
Condition
Multiple Sclerosis, Relapsing-Remitting
Intervention
Interferon beta-1b, FRP within 15 days after randomization
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-05-29